Herein we have shown that brain glucose hypometabolism measured by using [18F]FDG-PET neuroimaging, as well as the signs of peripheral glucose metabolism dysfunction are features of the transgenic tau-VLW mouse model of tauopathy making this model as a useful tool to study the mechanisms underlying the complex relationship between neurological disorders and glucose metabolism dysfunction. This evidence concerns the gene MAPT and nervous system disorder.